Literature DB >> 2320573

Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets.

D Safer1, R Golla, V T Nachmias.   

Abstract

Resting human platelets contain approximately 0.3 mM unpolymerized actin. When freshly drawn and washed platelets are treated with saponin, 85-90% of the unpolymerized actin diffuses out. Analysis by polyacrylamide gel electrophoresis under nondenaturing conditions shows that the bulk of this unpolymerized actin migrates with a higher mobility than does pure G-actin, profilactin, or actin-gelsolin complex. When muscle G-actin is added to fresh or boiled saponin extract, the added muscle actin is shifted to the high-mobility form. The saponin extract contains an acidic peptide having a molecular mass in the range of 5 kDa, which has been purified to homogeneity by reverse-phase HPLC. This peptide also shifts muscle actin to the high-mobility form. Addition of either boiled saponin extract or the purified peptide to muscle G-actin also strongly and stoichiometrically inhibits salt-induced polymerization, as assayed by falling-ball viscometry and by sedimentation. We conclude that this peptide binds to the bulk of the unpolymerized actin in platelets and prevents it from polymerizing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320573      PMCID: PMC53724          DOI: 10.1073/pnas.87.7.2536

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Comparison of the effects of phorbol 12-myristate 13-acetate and prostaglandin E1 on calcium regulation in human platelets.

Authors:  K Yoshida; F Stark; V T Nachmias
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

2.  The primary structure of human platelet profilin: reinvestigation of the calf spleen profilin sequence.

Authors:  C Ampe; F Markey; U Lindberg; J Vandekerckhove
Journal:  FEBS Lett       Date:  1988-02-08       Impact factor: 4.124

3.  Two monoclonal antibodies to actin: one muscle selective and one generally reactive.

Authors:  J L Lessard
Journal:  Cell Motil Cytoskeleton       Date:  1988

Review 4.  Actin and actin-binding proteins. A critical evaluation of mechanisms and functions.

Authors:  T D Pollard; J A Cooper
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

5.  ADP-ribosylation of skeletal muscle and non-muscle actin by Clostridium perfringens iota toxin.

Authors:  B Schering; M Bärmann; G S Chhatwal; U Geipel; K Aktories
Journal:  Eur J Biochem       Date:  1988-01-15

6.  Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin.

Authors:  I Lassing; U Lindberg
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

7.  Purification and characterization of actobindin, a new actin monomer-binding protein from Acanthamoeba castellanii.

Authors:  P K Lambooy; E D Korn
Journal:  J Biol Chem       Date:  1986-12-25       Impact factor: 5.157

8.  Microinjection of gelsolin into living cells.

Authors:  J A Cooper; J Bryan; B Schwab; C Frieden; D J Loftus; E L Elson
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

9.  Reversible binding of actin to gelsolin and profilin in human platelet extracts.

Authors:  S E Lind; P A Janmey; C Chaponnier; T J Herbert; T P Stossel
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

10.  Components of the cytoskeleton in the retinal pigmented epithelium of the chick.

Authors:  N J Philp; V T Nachmias
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  42 in total

1.  The control of actin nucleotide exchange by thymosin beta 4 and profilin. A potential regulatory mechanism for actin polymerization in cells.

Authors:  P J Goldschmidt-Clermont; M I Furman; D Wachsstock; D Safer; V T Nachmias; T D Pollard
Journal:  Mol Biol Cell       Date:  1992-09       Impact factor: 4.138

2.  A mechanistic model of the actin cycle.

Authors:  M Bindschadler; E A Osborn; C F Dewey; J L McGrath
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

3.  The interaction of actin with thymosin beta 4.

Authors:  D Safer
Journal:  J Muscle Res Cell Motil       Date:  1992-06       Impact factor: 2.698

Review 4.  Compare and contrast actin filaments and microtubules.

Authors:  T J Mitchison
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

5.  Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells.

Authors:  M C Sanders; A L Goldstein; Y L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.

Authors:  Sebastian C J Steiniger; Judith A Coppinger; Jörg A Krüger; John Yates; Kim D Janda
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

7.  Structural basis of thymosin-β4/profilin exchange leading to actin filament polymerization.

Authors:  Bo Xue; Cedric Leyrat; Jonathan M Grimes; Robert C Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

8.  Different thymosin Beta 4 immunoreactivity in foetal and adult gastrointestinal tract.

Authors:  Sonia Nemolato; Tiziana Cabras; Flaviana Cau; Mattia Umberto Fanari; Daniela Fanni; Barbara Manconi; Irene Messana; Massimo Castagnola; Gavino Faa
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

9.  Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse.

Authors:  Christopher F Spurney; Hee-Jae Cha; Arpana Sali; Gouri S Pandey; Emidio Pistilli; Alfredo D Guerron; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

Review 10.  The beta-thymosins, small actin-binding peptides widely expressed in the developing and adult cerebellum.

Authors:  Jaime Gómez-Márquez; Ramón Anadón
Journal:  Cerebellum       Date:  2002-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.